Cargando…

Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia

BACKGROUND/AIMS: We investigated the utility of serum C-reactive protein (CRP) and procalcitonin (PCT) for differentiating pulmonary tuberculosis (TB) from bacterial community-acquired pneumonia (CAP) in South Korea, a country with an intermediate TB burden. METHODS: We conducted a prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Young Ae, Kwon, Sung-Youn, Yoon, Ho IL, Lee, Jae Ho, Lee, Choon-Taek
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784977/ https://www.ncbi.nlm.nih.gov/pubmed/19949732 http://dx.doi.org/10.3904/kjim.2009.24.4.337

Ejemplares similares

Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP)
por: Kim, Eun Sun, et al.
Publicado: (2018)

Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia
por: Stockmann, Chris, et al.
Publicado: (2018)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

Pneumonia severity index in viral community acquired pneumonia in adults
por: Kim, Mi-Ae, et al.
Publicado: (2019)

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021)

Impact of Toxocariasis in Patients with Unexplained Patchy Pulmonary Infiltrate in Korea
por: Yoon, Young-Soon, et al.
Publicado: (2009)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia
por: Keramat, Fariba, et al.
Publicado: (2018)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Community-Acquired Pneumonia, Bacterial
por: File, Thomas M.
Publicado: (2012)

The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis
por: Kwon, Byoung Soo, et al.
Publicado: (2020)

Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia
por: Wang, Wenlong, et al.
Publicado: (2020)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Interleukin-5, interleukin-6, interferon induced protein-10, procalcitonin and C-reactive protein among mechanically ventilated severe community-acquired viral and bacterial pneumonia patients
por: Karhu, Jaana, et al.
Publicado: (2019)

Drug-induced Hepatotoxicity of Anti-tuberculosis Drugs and Their Serum Levels
por: Jeong, Ina, et al.
Publicado: (2015)

Chest Computed Tomography (CT) Immediately after CT-Guided Transthoracic Needle Aspiration Biopsy as a Predictor of Overt Pneumothorax
por: Noh, Tae June, et al.
Publicado: (2009)

Role of procalcitonin and C‐reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia
por: Ahn, Shin, et al.
Publicado: (2011)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

Correlation between plasma peroxides and procalcitonin levels in patients with severe streptococcal community acquired pneumonia
por: Borrelli, E, et al.
Publicado: (2002)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
por: Boussekey, N., et al.
Publicado: (2005)

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia
por: Gilbert, David, et al.
Publicado: (2016)

Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
por: Schuetz, Philipp
Publicado: (2020)

Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review
por: Ozbay, Sedat, et al.
Publicado: (2023)

Association of C-Reactive Protein and Outcome in Patients With Community-Acquired Pneumonia
por: Park, JK, et al.
Publicado: (2015)

Role of the Neutrophil-Lymphocyte Count Ratio in the Differential Diagnosis between Pulmonary Tuberculosis and Bacterial Community-Acquired Pneumonia
por: Yoon, Neul-Bom, et al.
Publicado: (2013)

Community-acquired bacterial pneumonia in adults: An update
por: Eshwara, Vandana Kalwaje, et al.
Publicado: (2020)

Clinical Characteristics of Community-Acquired Viridans Streptococcal Pneumonia
por: Choi, Sun Ha, et al.
Publicado: (2015)

Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia
por: Zheng, Nan, et al.
Publicado: (2020)

Impact of bacterial and viral coinfection in community-acquired pneumonia in adults
por: Lim, Yong Kwan, et al.
Publicado: (2019)

PNEUMONIA | Community Acquired Pneumonia, Bacterial and Other Common Pathogens
por: Niederman, M.S.
Publicado: (2006)

Comparison of Prognostic Performance between Procalcitonin and Procalcitonin-to-Albumin Ratio in Post Cardiac Arrest Syndrome
por: Yoon, Ju Hee, et al.
Publicado: (2023)

Devastating Community-Acquired Bacterial Meningitis Caused by Hypervirulent Klebsiella pneumoniae in an Immunocompetent Patient
por: Oh, Hyunjoo, et al.
Publicado: (2021)

Can we recognize severe community-acquired pneumonia without pneumonia severity index? Use of modified qSOFA with procalcitonin
por: Güleç, Tolgahan, et al.
Publicado: (2023)

Significance of fractional exhaled nitric oxide in chronic eosinophilic pneumonia: a retrospective cohort study
por: Park, Ji Young, et al.
Publicado: (2014)

Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana
por: Gersh, Jill K, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tv27sm4pvgdp6bvcl1j4560clk